UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells

Kidney international, 2017-12, Vol.92 (6), p.1458-1468

2017

Link zum Volltext

Verfügbarkeit prüfen

An update on the pathogenesis and treatment of IgA nephropathy

Kidney international, 2012-05, Vol.81 (9), p.833-843

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy

PloS one, 2016-12, Vol.11 (12), p.e0166830-e0166830

2016

Link zum Volltext

Verfügbarkeit prüfen

O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy

Journal of the American Society of Nephrology, 2006-12, Vol.17 (12), p.3520-3528

2006

Link zum Volltext

Verfügbarkeit prüfen

Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study

BMC nephrology, 2022-05, Vol.23 (1), p.178-178, Article 178

2022

Link zum Volltext

Verfügbarkeit prüfen

The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease

Biochemical journal, 2015-10, Vol.471 (2), p.167-185

2015

Link zum Volltext

Verfügbarkeit prüfen

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy

Glomerular diseases, 2022-01, Vol.2 (1), p.15-29

2022

Link zum Volltext

Verfügbarkeit prüfen

O-glycosylation of serum IgD in IgA nephropathy

Journal of the American Society of Nephrology, 2006-04, Vol.17 (4), p.1192-1199

2006

Link zum Volltext

Verfügbarkeit prüfen

The role of IgA in proximal tubular cell activation and tubulointerstitial scarring in IgA nephropathy

The Lancet (British edition), 2014-02, Vol.383, p.S34-S34

2014

Link zum Volltext

Verfügbarkeit prüfen

P0344NEFECON® (BUDESONIDE) SELECTIVELY REDUCES CIRCULATING LEVELS OF BAFF (BLYS) AND SOLUBLE BCMA AND TACI IN IGA NEPHROPATHY

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Link zum Volltext

Verfügbarkeit prüfen

FC049: Nefecon® (Budesonide) is an Epigenetic Modifier in IGA Nephropathy

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Link zum Volltext

Verfügbarkeit prüfen

4049 NEFECON® TREATMENT LIKELY MODULATES DOWNSTREAM PATHWAYS OF KIDNEY INFLAMMATION AND FIBROSIS IN IGA NEPHROPATHY

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Link zum Volltext

Verfügbarkeit prüfen

FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Link zum Volltext

Verfügbarkeit prüfen

FC050: Nefecon® Selectively Modifies the Composition of Circulating Immune Complexes in IGA Nephropathy

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Link zum Volltext

Verfügbarkeit prüfen

114 Complement protein autoantibodies and increased Factor H related protein four levels may contribute to pathogenesis in IgA nephropathy

Immunobiology (1979), 2023-09, Vol.228 (5), p.152565, Article 152565

2023

Link zum Volltext

Verfügbarkeit prüfen

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1

Journal of the American Society of Nephrology, 2017-07, Vol.28 (7), p.2158-2166

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic Activation of Neutrophils by Immune Complexes Is Critical to IgA Vasculitis

The Journal of immunology (1950), 2022-09, Vol.209 (6), p.1048-1058

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression

Kidney international, 2021-05, Vol.99 (5), p.1127-1139

2021

Link zum Volltext

Verfügbarkeit prüfen

Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis

Journal of the American Academy of Dermatology, 2019-11, Vol.81 (5), p.1078-1085

2019

Link zum Volltext

Verfügbarkeit prüfen

208. GALACTOSE DEFICIENT IGA1 (GD-IGA1) IN SKIN AND SERUM FROM PATIENTS WITH SKIN-LIMITED AND SYSTEMIC IGA VASCULITIS

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial

Kidney international, 2024-02, Vol.105 (2), p.381-388

2024

Link zum Volltext

Verfügbarkeit prüfen

SaO023THE LEVELS OF ABERRANTLY GALACTOSYLATED IGA1 ARE ASSOCIATED WITH THE RISK OF DEVELOPING PROGRESSIVE RENAL DISEASE IN IGA NEPHROPATHY

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii33-iii33

2015

Link zum Volltext

Verfügbarkeit prüfen

SP011SERUM IGA1 HINGE REGION O-GLYCOSYLATION IS A HERITABLE TRAIT IN CAUCASIANS

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii384-iii384

2015

Link zum Volltext

Verfügbarkeit prüfen

Macrophage interactions with collecting duct epithelial cells are capable of driving tubulointerstitial inflammation and fibrosis in immunoglobulin A nephropathy

Nephrology, dialysis, transplantation, 2020-11, Vol.35 (11), p.1865-1877

2020

Link zum Volltext

Verfügbarkeit prüfen

SP083TGF-ΒETA 1 RELEASE FROM PTEC IS STIMULATED BY GALACTOSE-DEFICIENT POLYMERIC IGA1

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii406-iii406

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(32)
Humans
(29)
Male
(18)
Female
(16)
Biological And Medical Sciences
(9)
Middle Aged
(9)
Urology & Nephrology
(9)
Glomerulonephritis, Iga - Pathology
(8)
Iga Nephropathy
(8)
Adult
(7)
Glomerulonephritis
(7)
Glycosylation
(7)
Immunoglobulin A
(7)
Medical Sciences
(7)
Child
(6)
Nephrology
(6)
Child, Preschool
(5)
Glomerulonephritis, Iga - Immunology
(5)
Immunoglobulin A - Metabolism
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells

An update on the pathogenesis and treatment of IgA nephropathy

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy

O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy

Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study

The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy

O-glycosylation of serum IgD in IgA nephropathy

The role of IgA in proximal tubular cell activation and tubulointerstitial scarring in IgA nephropathy

P0344NEFECON® (BUDESONIDE) SELECTIVELY REDUCES CIRCULATING LEVELS OF BAFF (BLYS) AND SOLUBLE BCMA AND TACI IN IGA NEPHROPATHY

FC049: Nefecon® (Budesonide) is an Epigenetic Modifier in IGA Nephropathy

4049 NEFECON® TREATMENT LIKELY MODULATES DOWNSTREAM PATHWAYS OF KIDNEY INFLAMMATION AND FIBROSIS IN IGA NEPHROPATHY

FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients

FC050: Nefecon® Selectively Modifies the Composition of Circulating Immune Complexes in IGA Nephropathy

114 Complement protein autoantibodies and increased Factor H related protein four levels may contribute to pathogenesis in IgA nephropathy

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1

Systemic Activation of Neutrophils by Immune Complexes Is Critical to IgA Vasculitis

Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression

Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis

208. GALACTOSE DEFICIENT IGA1 (GD-IGA1) IN SKIN AND SERUM FROM PATIENTS WITH SKIN-LIMITED AND SYSTEMIC IGA VASCULITIS

Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial

SaO023THE LEVELS OF ABERRANTLY GALACTOSYLATED IGA1 ARE ASSOCIATED WITH THE RISK OF DEVELOPING PROGRESSIVE RENAL DISEASE IN IGA NEPHROPATHY

SP011SERUM IGA1 HINGE REGION O-GLYCOSYLATION IS A HERITABLE TRAIT IN CAUCASIANS

Macrophage interactions with collecting duct epithelial cells are capable of driving tubulointerstitial inflammation and fibrosis in immunoglobulin A nephropathy

SP083TGF-ΒETA 1 RELEASE FROM PTEC IS STIMULATED BY GALACTOSE-DEFICIENT POLYMERIC IGA1

Suchergebnisse filtern